Brainstorm Cell Therapeutics ( (BCLI) ) has released its Q4 earnings. Here is a breakdown of the information Brainstorm Cell Therapeutics presented to its investors.
BrainStorm Cell Therapeutics Inc. is a pioneering company in the biotechnology sector, focusing on the development of autologous adult stem cell therapies for neurodegenerative diseases, with a notable emphasis on amyotrophic lateral sclerosis (ALS).